Marc Buyse is the founder of the International Drug Development Institute (IDDI), CluePoints and One2Treat, three companies offering biostatistical services in Europe and the US. He is also Associate Professor of Biostatistics at Universiteit Hasselt in Belgium. He holds degrees in engineering and statistics from Brussels University (ULB), management from the Cranfield School of Management (Cranfield, UK) and biostatistics from Harvard University (Boston, MA). He was President of the International Society for Clinical Biostatistics, President of the Quetelet Society, and Fellow of the Society for Clinical Trials. He worked at the EORTC (European Organization for Research and Treatment of Cancer) in Brussels and at the Dana Farber Cancer Institute in Boston prior to founding IDDI in 1991, CluePoints in 2012 and One2Treat in 2024.Specialties: See Marc's publications at: http://publicationslist.org/marc.buyse.